Therapeutic Expertise
BioPier is a leading biostatistics and programming provider with recognition as a trusted partner. We've been awarded contracts for important studies in Rare Disease, Oncology, and GI, with a focus on late-phase studies. With a strong reputation for high-quality results, we've served as primary provider for a major pharmaceutical company, the #1 rare disease company, and a preferred vendor for a top pharmaceutical company. Our expertise helps drive pivotal studies in oncology, gastroenterology, and hematology.
Oncology
- Leukemia (ALL, AML, CML, etc)
- Multiple Myeloma (MM)
- Lymphoma
- Myelodysplastic Syndrome (MDS)
- Systemic Mastocytosis (SM)
- Lung Cancer (NSCLC)
- Gastrointestinal Stromal Tumors
Gastroenterology
- Eosinophilic Esophagitis
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis and Crohn's Disease
- Liver Disease
Rare Genetic Disease
- Hereditary Angioedema (HAE)
- Hunter Syndrome
- Metachromatic Leukodystrophy (MLD)
- Gaucher Disease
- Fabry Disease
- Studies overlap with other therapeutic areas like SM, HAE
Hematology
- Thrombotic Thrombocytopenic Purpura (TTP)
- Hemophilia, von Willebrand disease (VWD)
- Rare Disorder of Mast Cells
Anti-Infectives
Vaccine
CNS and Psychiatry
Immunology
- Graft Versus Host Disease (GVHD)
- Studies overlap with other therapeutic areas like Immunodeficiency (HAE), Vaccines (Dengue, Influenza), Inflammation (IBD), and oncology (SM)